Home » Aclara BioSciences

Aclara BioSciences

Mar 24, 2000
Premium

Ž Aclara BioSciences of Mountain View, Calif., launched its IPO last week and saw its shares rise 53 percent from 21 to 32 1/8 in its first trading day, sa

id a Bloomberg report. The genomics and diagnostic tools provider sold 9 million shares and raised $189 million for the 29 percent stake.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

This Week in PLOS

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.

Try the Other Version

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

You Do Your Way

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

CRISPR Discussions

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

What's Popular?

In Informatics

  1. Stanford-Developed Approach Allows for More Private Analysis of Human Genomes

  2. CHOP to Head NIH-Backed Data Center for Pediatric Cancer Research

  3. Geneformics Sees Lossless Compression as Answer to Cloud Genomics

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.